OLYMPIC COOL-CAP

FDA Premarket Approval P040025

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the olympic cool-cap. The olympic cool-cap is indicated for use in full-term infants with clinical evidence of moderate to severe hypoxic-ischemic encephalopathy (hie). Cool-cap provides selective head cooling with mild systemic hypothermia to prevent or reduce the severity of neurologic injury associated with hie.

DeviceOLYMPIC COOL-CAP
Generic NameCap, Cooling (infants)
ApplicantNatus Medical Incorporated
Date Received2004-05-28
Decision Date2006-12-20
Notice Date2006-12-26
PMAP040025
SupplementS
Product CodeMXM 
Docket Number06M-0530
Advisory CommitteeNeurology
Expedited ReviewYes
Combination Product No
Applicant Address Natus Medical Incorporated 5900 First Avenue South seattle, WA 98108
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P040025Original Filing
S014 2013-06-26 Normal 180 Day Track No User Fee
S013 2013-05-28 Normal 180 Day Track
S012 2012-01-26 Real-time Process
S011 2010-09-29 Real-time Process
S010 2010-05-03 Real-time Process
S009 2009-07-21 Real-time Process
S008 2008-10-27 Real-time Process
S007 2008-07-16 Normal 180 Day Track
S006 2007-10-24 Real-time Process
S005 2007-08-24 30-day Notice
S004
S003
S002
S001

NIH GUDID Devices

Device IDPMASupp
00382830016308 P040025 000
00382830009584 P040025 000
00382830009577 P040025 000
00382830009560 P040025 000
00382830004169 P040025 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.